Singapore-based biotech Hummingbird Bioscience has outlicensed its lead immunotherapy candidate, HMBD-002, to Australian drug ...

Biogen’s salanersen has shown promise in slowing neuronal damage and opening new motor milestones, according to interim ...

Bayer’s (BAYN: DE) cell therapy subsidiary BlueRock Therapeutics is shifting its priorities, cutting around 50 jobs and ...